What's breaking now, across thousands of outlets.
(MedPage Today) -- A shorter cycle length for a standard treatment for refractory metastatic colorectal cancer was noninferior to the typical longer length for overall survival (OS), while limiting toxicity, the phase III PRABITAS trial from Japan...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Democrats are coalescing around a plan to offer Medicare to more Americans, if not all of them.
The Public Health Agency of Canada (PHAC) says it has found no evidence of a mystery brain disease that was allegedly affecting hundreds of New Brunswick residents.
Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies…
Doctors facing deluge of patients in hospitals warn low influenza vaccination rates will tip the health-care system over the edge
Pakistan has vaccinated more than 24 million children under five during its latest nationwide polio campaign, demonstrating the continued commitment of health authorities and frontline workers to…
Cost and access barriers are pushing people to modified use and unapproved versions.
